Stay updated with breaking news from Primary Hyperoxaluria Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved RivflozaTM (nedosiran) injection 80 mg, 128 mg, or...
Lucy Skinner is the first-ever Make-A-Wish Kid who will be walking in Denver Fashion Week on Sunday, May 7.
The Global Fuchs Endothelial Corneal Dystrophy Market Size was valued at USD 170 Billion in 2022 and the Worldwide Fuchs Endothelial Corneal Dystrophy...
More research from the National Kidney Foundation Spring Clinical Meeting
- OXLUMO Now Indicated for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patie